Emerging roles for immunomodulatory functions of free ISG15

Journal of Interferon and Cytokine Research

Volumn 33, Issue 12, 2013, Pages 728-738

  Campbell, Jessica A ^a   Lenschow, Deborah J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 3; INTERFERON STIMULATED GENE FACTOR 15; UBIQUITIN CONJUGATING ENZYME 13; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC LYMPHOCYTE; DRUG CONJUGATION; GENE DELETION; GENE SILENCING; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOMODULATION; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SECRETORY PATHWAY; SEQUENCE HOMOLOGY; UBIQUITINATION; UPREGULATION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; UBIQUITINS;

EID: 84890014779     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0064     Document Type: Review

References (87)

1. Blomstrom DC, Fahey D, Kutny R, Korant BD, Knight E, Jr. 1986. Molecular characterization of the interferon-induced 15- kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem 261(19): 8811-8816.
2. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson- Dupuis S, Casanova JL. 2012. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337(6102): 1684-1688.
3. Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, Lu M, Gerken G, Schlaak JF. 2010. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 59(8): 1111-1119.
4. Catic A, Fiebiger E, Korbel GA, Blom D, Galardy PJ, Ploegh HL. 2007. Screen for ISG15-crossreactive deubiquitinases. PLoS One 2(7):e679.
5. Chairatvit K, Wongnoppavich A, Choonate S. 2012. Upregulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-alpha via type I interferon-dependent and -independent pathways. Mol Cell Biochem 368(1-2): 195-201.
6. Clementz MA, Chen Z, Banach BS, Wang Y, Sun L, Ratia K, Baez-Santos YM, Wang J, Takayama J, Ghosh AK, Li K, Mesecar AD, Baker SC. 2010. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 84(9): 4619-4629.
7. Cottle LE. 2011. Mendelian susceptibility to mycobacterial disease. Clin Genet 79(1): 17-22.
8. D'Cunha J, Knight E, Jr., Haas AL, Truitt RL, Borden EC. 1996a. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A 93(1): 211-215.
9. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E, Jr., Borden EC. 1996b. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157(9): 4100-4108.
10. Dai J, Pan W, Wang P. 2011. ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Virol J 8:468.
11. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281(7): 4334-4338.
12. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95(26): 15623-15628.
13. Durfee LA, Lyon N, Seo K, Huibregtse JM. 2010. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 38(5): 722-732.
14. Farrell PJ, Broeze RJ, Lengyel P. 1979. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279(5713): 523-525.
15. Feng Q, Sekula D, Guo Y, Liu X, Black CC, Galimberti F, Shah SJ, Sempere LF, Memoli V, Andersen JB, Hassel BA, Dragnev K, Dmitrovsky E. 2008. UBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol Cancer Ther 7(12):3780- 3788.
16. Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A, Paragas J, Richt JA, Rowland RR, Schmaljohn CS, Lenschow DJ, Snijder EJ, Garcia-Sastre A, Virgin HWt. 2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2(6): 404-416.
17. Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, Virgin HW. 2009. ISG15 Arg151 and the ISG15- conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J Virol 83(4): 1602-1610.
18. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. 2005. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336(2): 496-506.
19. Gonzalez-Navajas JM, Lee J, David M, Raz E. 2012. Immunomodulatory functions of type I interferons. Nat Rev Immunol 12(2): 125-135.
20. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M. 2008. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4(7):e1000096.
21. Haas AL, Ahrens P, Bright PM, Ankel H. 1987. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262(23): 11315-11323.
22. Hamerman JA, Hayashi F, Schroeder LA, Gygi SP, Haas AL, Hampson L, Coughlin P, Aebersold R, Aderem A. 2002. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol 168(5): 2415-2423.
23. Harty RN, Pitha PM, Okumura A. 2009. Antiviral activity of innate immune protein ISG15. J Innate Immun 1(5): 397-404.
24. Hosono H, Yokosawa H. 2008. Small ubiquitin-related modifier is secreted and shows cytokine-like activity. Biol Pharm Bull 31(5): 834-837.
25. Hsiang TY, Zhao C, Krug RM. 2009. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 83(12): 5971-5977.
26. Hsiao NW, Chen JW, Yang TC, Orloff GM, Wu YY, Lai CH, Lan YC, Lin CW. 2010. ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells. Antiviral Res 85(3): 504-511.
27. Jeon YJ, Choi JS, Lee JY, Yu KR, Kim SM, Ka SH, Oh KH, Kim KI, Zhang DE, Bang OS, Chung CH. 2009. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep 10(4): 374-380.
28. Jeon YJ, Jo MG, Yoo HM, Hong SH, Park JM, Ka SH, Oh KH, Seol JH, Jung YK, Chung CH. 2012. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. J Clin Invest 122(7): 2622-2636.
29. Ketscher L, Basters A, Prinz M, Knobeloch KP. 2012. mHERC6 is the essential ISG15 E3 ligase in the murine system. Biochem Biophys Res Commun 417(1): 135-140.
30. Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. 2004. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol 24(21):9592- 9600.
31. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. 2006. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 26(2): 472-479.
32. Kim KI, Zhang DE. 2005. UBP43, an ISG15-specific deconjugating enzyme: expression, purification, and enzymatic assays. Methods Enzymol 398: 491-499.
33. Kim MJ, Hwang SY, Imaizumi T, Yoo JY. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 82(3):1474- 1483.
34. KimT, Pazhoor S, BaoM, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J, Liu YJ. 2010. Aspartateglutamate- alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 107(34):15181- 15186.
35. Knight E, Jr., Cordova B. 1991. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J Immunol 146(7): 2280-2284.
36. Knight E, Jr., Fahey D, Cordova B, Hillman M, Kutny R, Reich N, Blomstrom D. 1988. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem 263(10): 4520-4522.
37. Knobeloch KP. 2010. In vivo functions of isgylation. Subcell Biochem 54:215-227.
38. Kuang Z, Seo EJ, Leis J. 2011. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol 85(14): 7153-7161.
39. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ. 2009. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83(2): 1147-1151.
40. Lenschow DJ. 2010. Antiviral properties of ISG15. Viruses 2(10): 2154-2168.
41. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, Schmidt RE, Levine B, Virgin HWt. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79(22): 13974-13983.
42. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HW. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104(4): 1371-1376.
43. Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Menard R. 2005. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J Virol 79(24): 15199-15208.
44. Liu M, Li XL, Hassel BA. 2003. Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. J Biol Chem 278(3): 1594-1602.
45. Loeb KR, Haas AL. 1992. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267(11): 7806-7813.
46. Lu G, Reinert JT, Pitha-Rowe I, Okumura A, Kellum M, Knobeloch KP, Hassel B, Pitha PM. 2006. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 52(1): 29-41.
47. Majetschak M. 2011. Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern molecules. J Leukoc Biol 89(2): 205-219.
48. Malakhova O, Malakhov M, Hetherington C, Zhang DE. 2002. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem 277(17): 14703-14711.
49. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 283(14): 8783-8787.
50. Nakamura M, Nagata T, Xavier M, Tanigawa Y. 1996. Ubiquitinlike polypeptide inhibits the IgE response of lipopolysaccharide- activated B cells. Int Immunol 8(11): 1659-1665.
51. Nakasato N, Ikeda K, Urano T, Horie-Inoue K, Takeda S, Inoue S. 2006. A ubiquitin E3 ligase Efp is up-regulated by interferons and conjugated with ISG15. Biochem Biophys Res Commun 351(2): 540-546.
52. Narasimhan J, Wang M, Fu Z, Klein JM, Haas AL, Kim JJ. 2005. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem 280(29): 27356-27365.
53. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103(5): 1440-1445.
54. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A 105(10): 3974-3979.
55. Okumura F, Okumura AJ, Uematsu K, Hatakeyama S, Zhang DE, Kamura T. 2012. Activation of double-stranded RNAactivated protein kinase (PKR) by interferon stimulated gene 15 (ISG15) modification down-regulates protein translation. J Biol Chem 288(4): 2839-2847.
56. Okumura F, Zou W, Zhang DE. 2007. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev 21(3): 255-260.
57. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25(15): 6338-6345.
58. Oudshoorn D, van Boheemen S, Sanchez-Aparicio MT, Rajsbaum R, Garcia-Sastre A, Versteeg GA. 2012. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS One 7(1):e29870.
59. Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, Kambara H. 2003. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun 309(3): 533-539.
60. Padovan E, Terracciano L, Certa U, Jacobs B, Reschner A, Bolli M, Spagnoli GC, Borden EC, Heberer M. 2002. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res 62(12): 3453-3458.
61. Pincetic A, Kuang Z, Seo EJ, Leis J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol 84(9): 4725-4736.
62. Potter JL, Narasimhan J, Mende-Mueller L, Haas AL. 1999. Precursor processing of pro-ISG15/UCRP, an interferon-betainduced ubiquitin-like protein. J Biol Chem 274(35):25061- 25068.
63. Recht M, Borden EC, Knight E, Jr. 1991. A human 15-kDa IFNinduced protein induces the secretion of IFN-gamma. J Immunol 147(8): 2617-2623.
64. Saini V, Marchese A, Majetschak M. 2010. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J Biol Chem 285(20): 15566-15576.
65. Shah SJ, Blumen S, Pitha-Rowe I, Kitareewan S, Freemantle SJ, Feng Q, Dmitrovsky E. 2008. UBE1L represses PML/ RAR{alpha} by targeting the PML domain for ISG15ylation. Mol Cancer Ther 7(4): 905-914.
66. Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30(10): 2424-2436.
67. Skaug B, Chen ZJ. 2010. Emerging role of ISG15 in antiviral immunity. Cell 143(2): 187-190.
68. Takeuchi T, Inoue S, Yokosawa H. 2006a. Identification and Herc5-mediated ISGylation of novel target proteins. Biochem Biophys Res Commun 348(2): 473-477.
69. Takeuchi T, Iwahara S, Saeki Y, Sasajima H, Yokosawa H. 2005. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme. J Biochem 138(6): 711-719.
70. Takeuchi T, Kobayashi T, Tamura S, Yokosawa H. 2006b. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett 580(18): 4521-4526.
71. Takeuchi T, Yokosawa H. 2005. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem Biophys Res Commun 336(1): 9-13.
72. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. 2012. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249(1): 158-175.
73. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, Bu Z, Chen H, Wang C. 2010. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol 184(10): 5777-5790.
74. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11(11):997- 1004.
75. Versteeg GA, Hale BG, van Boheemen S, Wolff T, Lenschow DJ, Garcia-Sastre A. 2010. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J Virol 84(10): 5423-5430.
76. Wang W, Zhang M, Xiao ZZ, Sun L. 2012. Cynoglossus semilaevis ISG15: a secreted cytokine-like protein that stimulates antiviral immune response in a LRGG motif-dependent manner. PLoS One 7(9):e44884.
77. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ. 2011. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 7(10):e1002322.
78. Wong JJ, Pung YF, Sze NS, Chin KC. 2006. HERC5 is an IFNinduced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 103(28): 10735-10740.
79. Xia ZP, Sun L, Chen X, Pineda G, Jiang X, Adhikari A, Zeng W, Chen ZJ. 2009. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461(7260): 114-119.
80. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20(3): 362-371.
81. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, Chen ZJ. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141(2): 315-330.
82. Zhang D, Zhang DE. 2011. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res 31(1): 119-130.
83. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. 2004. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFNalpha/ beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 101(20): 7578-7582.
84. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102(29):10200- 10205.
85. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A 107(5):2253- 2258.
86. Zou W, Papov V, Malakhova O, Kim KI, Dao C, Li J, Zhang DE. 2005. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun 336(1): 61-68.
87. Zou W, Wang J, Zhang DE. 2007. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation. Biochem Biophys Res Commun 354(1):321-327.